ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Year in Review 2024 - Ovarian Cancer

Oncology 2024 Year in Review

E. Crane

Updates in the Management of Cervical Cancer

Abdulrahman Sinno

Cancer Screening Molecular Tools

Fengting Yan

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan

IOTA Terms and Definitions: How Should You Describe an Adnexal Mass?

International Society of Ultrasound in Obstetrics and Gynecology

C. Landolfo

Genetic Testing in Determining Maintenance Treatment Options in Adva…

Alexander Olawaiye

Defining Platinum Resistance in Ovarian Cancer

Michael Birrer

2024 Updates in Ovarian Cancer

Total Health

T. Tillmanns

Ovarian Cancer Patient Experience With Niraparib: Assessing QoL Data…

Erin Crane

UChicago Medicine Best of ASCO® 2024: Options for Recurrent Platinum…

UChicago Medicine Annual Practice Updates in Hematology and Oncology

H. Cun

Precision Oncology in the Management of Ovarian Cancer

Miami Cancer Institute Precision Oncology Symposium

D. Dizon

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

UCLA Health

G. Konecny

Treatment Updates in Cervical & Ovarian Cancer

University of Illinois Cancer Center

J. Ray

ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New…

2024 ESMO Annual Meeting Insights Hub

S. Banerjee

Overview of Ovarian Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

2024 Updates in Cervical Cancer

Total Health

T. Tillmanns